Skip to main content
. Author manuscript; available in PMC: 2011 Jan 20.
Published in final edited form as: Behav Brain Res. 2009 Sep 24;206(2):286–292. doi: 10.1016/j.bbr.2009.09.028

Fig. 2.

Fig. 2

Infusions of anti-sense oligonucleotides for DARPP-32 to the VTA reduce P4 and/or SKF38393-facilitated total lordosis durations (TLDs, mean ± SEM) of ovx, E2-primed hamsters. Inset is schematic representation of hamster coronal sections depicting the VTA. Infusion sites within the VTA are designated with closed circles and infusion sites outside of the VTA are indicated with closed squares and a small arrow. * SKF38393 vs. vehicle, p <0.05. ^ Anti-sense vs. sense oligonucleotide, p <0.05